PedAM
Pediatric Disease Annotations & Medicines
| Disease | oligodendroglioma |
| Phenotype | C0017636|glioblastoma |
| Sentences | 14 |
| PubMedID- 24022617 | The entire lesion was surgically removed and was found to be a glioblastoma with an extensive oligodendroglioma component. |
| PubMedID- 25151507 | The subjectivity in pathological diagnosis of anaplastic oligoastrocytoma (aoa) and uncertainty in designation of glioblastoma with oligodendroglioma component (gbmo) were two major dilemmas which puzzled neuro-pathologists and neurosurgeons. |
| PubMedID- 22326863 | glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome. |
| PubMedID- 22736234 | On histopathological review, only one gbm was diagnosed as glioblastoma with oligodendroglioma component (gbmo). |
| PubMedID- 25500080 | Prognosis of glioblastoma with oligodendroglioma component is associated with the idh1 mutation and mgmt methylation status. |
| PubMedID- 25853013 | The distribution pattern and uptake value of 11c-4dst in the tumor are almost identical to those of 18f-flt except one non-enhanced primary diffuse astrocytoma and one recurrent glioblastoma with oligodendroglioma component in which only 18f-flt could detect the tumor well, whereas 11c-4dst showed no and a faint uptake in the tumors, respectively. |
| PubMedID- 26232204 | Introduction: the aim of this study is to investigate perfusion characteristics of glioblastoma with an oligodendroglioma component (gbmo) compared with conventional glioblastoma (gbm) using dynamic susceptibility contrast (dsc) perfusion magnetic resonance (mr) imaging and microvessel density (mvd). |
| PubMedID- 24387276 | Another report described an aggressive clinical phenotype (8-month overall survival) characterizing a pediatric glioblastoma with an oligodendroglioma component, displaying neither idh1/2 mutation nor 1p/19q co-deletion[40], which was clearly different from the case reported here. |
| PubMedID- 23289977 | A recently recognized subtype, glioblastoma with oligodendroglioma component (gbm-o), was designated by the world health organization (who) in 2007. |
| PubMedID- 24745708 | The diagnosis of glioma was established in 3 of 5 cases in which definitive diagnosis was not obtained using frozen sections, and information was obtained for the discrimination of glioblastoma or glioblastoma with an oligodendroglioma component from anaplastic glioma or secondary glioblastoma. |
| PubMedID- 24118308 | A new der(1;7)(q10;p10) leading to a singular 1p loss in a case of glioblastoma with oligodendroglioma component. |
| PubMedID- 23530875 | Pediatric glioblastoma with oligodendroglioma component: aggressive clinical phenotype with distinct molecular characteristics. |
| PubMedID- 22911839 | The favorable prognosis of high-grade oligodendroglial tumor such as glioblastoma (gbm) with oligodendroglioma component (gbmo) has been suggested; however, the studies which examine the prognostic significance of oligodendroglial tumor were limited. |
| PubMedID- 25354913 | The most recent definition of glioblastoma with oligodendroglioma component (gbmo) assigned clinical significance to the observation of oligodendroglial foci within glioblastomas. |
Page: 1